Louisiana State University

LSU Digital Commons
Faculty Publications

Department of Chemistry

1-1-1988

Platelet-derived growth factor mRNA detection in human
atherosclerotic plaques by in situ hybridization
J. N. Wilcox
Genentech Incorporated

K. M. Smith
Genentech Incorporated

L. T. Williams
Genentech Incorporated

S. M. Schwartz
Genentech Incorporated

D. Gordon
Genentech Incorporated

Follow this and additional works at: https://digitalcommons.lsu.edu/chemistry_pubs

Recommended Citation
Wilcox, J., Smith, K., Williams, L., Schwartz, S., & Gordon, D. (1988). Platelet-derived growth factor mRNA
detection in human atherosclerotic plaques by in situ hybridization. Journal of Clinical Investigation, 82
(3), 1134-1143. https://doi.org/10.1172/JCI113671

This Article is brought to you for free and open access by the Department of Chemistry at LSU Digital Commons. It
has been accepted for inclusion in Faculty Publications by an authorized administrator of LSU Digital Commons.
For more information, please contact ir@lsu.edu.

Rapid Publication
Platelet-derived Growth Factor rnRNA Detection in Human
Atherosclerotic Plaques by In Situ Hybridization
Josiah N. Wilcox,* Kathleen M. Smith,* Lewis T. Williams,* Stephen M. Schwartz, and David Gordon

*Department of Cardiovascular Research, Genentech, Inc., South San Francisco, California 94080; tHoward Hughes Medical Institute,
University ofCalifornia, San Francisco, California 94143; IDepartment ofPathology, University of Washington, Seattle,
Washington 98195

Abstract
Platelet-derived growth factor (PDGF) mRNA, and mRNA for
its receptor, have been localized to specific cell types within the
human atherosclerotic plaque, using in situ hybridization. The
predominant cell types found to express PDGF A and B chain
mRNA are mesenchymal-appearing intimal cells and endotheHal cells, respectively, with little or no expression detected- in
macrophages. The distribution of PDGF receptor mRNA containing cells was also examined and found to be localized predominantly in the plaque intima.

Introduction
Platelet-derived growth factor (PDGF)' is a dimer composed
of two homologous polypeptide chains, A and B (1, 2). The
genes encoding these polypeptide chains have been mapped to
different chromosomes (3, 4) and their expression is independently regulated (3). The gene encoding PDGF B chain
mRNA is c-sis which is the cellular counterpart to the v-sis
gene of simian sarcoma virus (5-7). PDGF has been hypothesized to be responsible for intimal proliferation in atherosclerosis. This hypothesis originated with the observations that
platelets contain a mitogen for smooth muscle and that platelets accumulate and release their granules at sites of endothelial denudation (8, 9). The source of PDGF was therefore presumed to be external to the vessel wall, in the form of blood
borne platelets. A requirement for platelets, however, could
not explain certain experimental observations. With hypercholesterolemia, smooth muscle proliferation can precede the
loss of endothelium (10). In hypertension, smooth muscle replication occurs without recognizable endothelial denudation
(11-14). Finally, in the balloon-injured rat carotid artery,
smooth muscle proliferation continues long after most of the
platelet interaction with the vessel wall has ceased (15-17).
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Subsequent studies in PDGF biology revealed that many
cell types, including macrophages (18-21), endothelial cells
(22-24) and even arterial smooth muscle cells (25-27) can
produce PDGF, at least in vitro. Since these same cell types are
present in human atherosclerotic plaques (28, 29), the PDGF
hypothesis of atherogenesis has been modified to include the
possible production of PDGF from within the developing
human intima (30). Indeed, local synthesis of PDGF in the
atheroma is supported by recent studies showing that PDGF B
chain mRNA can be detected by Northern blots of human
carotid plaques removed at surgery (31).
In the present series of experiments we report the first successful detection of PDGF gene expression within the human
atherosclerotic plaque by in situ hybridization.

Methods
In situ hybridizations. In situ hybridizations were carried out as described previously (32-35). Human carotid endarterectomy specimens
were obtained from surgery and within 15 min of removal fixed in 4%
paraformaldehyde 0.1 M sodium phosphate buffer for 3-18 h at 40C
followed by immersion in sterile 15% sucrose PBS overnight at 40C.
The tissue was then frozen in O.C.T. (Miles Scientific, Elkhart, IN) and
7 gm frozen sections thaw-mounted onto polylysine-coated slides and
stored at -70'C with desiccant. Before hybridization the sections were
pretreated with paraformaldehyde (10 min) and proteinase K (1 ,ug/ml)
(10 min), prehybridized for 1-2 h in 50 Ml of prehybridization buffer
(0.3 M NaCl, 20 mM Tris pH8.0, 5 mM EDTA, i X Denhardt's solution, 10% dextran sulfate, and 10 mM DTT). The hybridizations were
started by adding 300,000 cpm of the "5S-riboprobe in a small amount
of prehybridization buffer. After hybridization the sections were
washed with 2X SSC (2 X 10 min) (1X SSC = 150 mM NaCl, 15 mM
Na citrate, pH 7.0), treated with RNase (20 ug/ml, 30 min room
temperature), washed in 2X SSC (2 X 10 min), followed by a high
stringency wash in 0.1 X SSC at 520C for 2 h. All SSC solutions up to
this point of the procedure contained 10 mM fl-mercaptoethanol and 1
mM EDTA to help prevent nonspecific binding of the probe. The
tissue was then washed in 0.5X SSC without fl-mercaptoethanol (2
X 10 min) and dehydrated by immersion in graded alcohols containing
0.3 M NH4Ac. The sections were dried and coated with NTB2 nuclear
emulsion (Kodak Co.) and exposed in the dark at 41C for 4 to 8 wk.
After developing the sections were counterstained with hematoxylin
and eosin.
Probes. Probes specific to PDGF A chain (3), PDGF B chain (5),
PDGF receptor (36) or transforming growth factor alpha (TGF-a) (37)
were labeled by transcription (38) using 3S-labeled UTP (sp act 1,200
Ci/mmol; Amersham Corp., North Chicago, IL). The final specific
activity of these probes was 300 Ci/mmol.
To control for the possibility that some tissues might show a vatiable hybridization response dependent on postoperative handling,
each tissue was probed first with synthetic oligomers to human von
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media. PDGF receptor mRNA could be identified in cells
found primarily in the plaque intima co-localized in plaque
regions synthesizing A and B chain mRNA with a few positive
cells detected in the tunica media.
We used multiple probes to confirm the specificity of the
hybridization reaction and to control for the possibility that
hybridizations at tissue edges could represent a form of edge
artefact. Serial sections from every experiment were hybridized with 35S-labeled cRNAs to: PDGF A, PDGF B, PDGF
receptor, or to transforming growth factor-alpha (TGF-a).
These probes were all labeled to the same specific activity and
equivalent amounts of each radioactive probe were added to
the hybridization reactions. Each probe gave distinct, different
patterns of hybridization. Positive autoradiography was not
seen at the cut edges of the media or plaque using the TGF-a
or PDGF receptor probes. In no case was positive TGF-a hybridization seen on any vascular section examined, and so this
probe served as a negative control for every hybridization. The
TGF-a probe was however effective in labeling epidermal cells
in normal human skin using the same methodology (46).
As already noted, we observed a strong correlation between
those plaque regions making PDGF B-chain mRNA and the
intraplaque capillaries. Examination of this tissue at higher
magnification suggested that endothelial cells were a major site
of PDGF B-chain synthesis since positive cells were found at
the luminal surfaces (Fig. 2). Serial sections stained with antivWf or Ulex Europaeus lectin confirmed that endothelial cells
were present at the luminal surfaces of these vascular profiles.
Serial sections hybridized with A-chain specific probes
showed less intense labeling of endothelial cells. However,
some vascular profiles appeared to express both A and B
chains (Fig. 2). More often, A-chain hybridization was found
in cells adjacent to the endothelium in the capillary wall (Fig. 2
D) or in mesenchymal-appearing intimal cells (Fig. 3). Only
Results
occasional endothelial-appearing cells displayed A-chain hybridization, whereas most of such cells displayed B-chain hybridization.
Expression of PDGF and PDGF receptor mRNA by plaque
Not all plaque capillary profiles expressed PDGF. More
regions. Serial 10-,m sections of eight human carotid atherosclerotic plaques removed at surgery were hybridized to 35S-laplaque capillaries could be identified by reactivity to anti-vWf
beled PDGF A- or B-chain-specific cRNA probes. The most
antibody or with the Ulex Europaeus lectin than were positive
immediately impressive result was the recognition at low magby in situ hybridization for either PDGF A- or B-chain
nification that the mRNAs for both chains of PDGF were
mRNA. To control for the possibility that not all endothelial
distributed nonrandomly within the plaque, and involved a
cells had mRNA available for hybridization, some serial secsubset of cells. Based on cell counts performed on random
tions were hybridized with the oligomer directed against vWf
sections of four carotid plaques 7.2% of all plaque cells
mRNA tailed with [35S]CTP. A comparison of this in situ vWf
counted (308/4306 cells) showed hybridization for B-chain
labeling to that of PDGF B chain confirmed that there were
and 15.2% (669/4405 cells) revealed PDGF A-chain hybridizamore capillary endothelial-appearing cells containing vWf
mRNA than PDGF B-chain mRNA supporting our hypothtion. Similarly 6.5% of all cells (251/3888 cells) revealed
PDGF receptor hybridization.
esis that there is a subset of endothelial cells making PDGF B
Cells containing mRNA encoding both PDGF A and B
chain mRNA.
chains could be detected in similar locations in the plaque (Fig.
PDGF B chain mRNA was also detected in endothelial
cells of normal internal mammary artery (Fig. 2 E). In these
1, A and B). Cells containing the mRNA for the B-chain of
PDGF were most prominent at the lumenal edges of vascular
same internal mammary artery specimens, little hybridization
structures and in plaque regions rich in small, penetrating
was seen with the PDGF A-chain probe (Fig. 2 F) or the
blood vessels (Fig. 1 B). Cells containing the mRNA for the A
PDGF receptor probe, and none was seen with the TGF-a
chain of PDGF were found over similar vascularized plaque
probe (results not shown). The background was very low for all
of these probes, confirming the specificity of our result to the B
regions (Fig. 1 A) but also over sparsely distributed mesenchychain of PDGF. Few or no macrophages were detected in these
mal-appearing intimal cells distributed in the fibrous portions
of the plaque (Fig. 3). Areas with large numbers of foam cells,
tissues by immunocytochemistry on serial sections.
most of which appeared to be macrophages did not show
Macrophages, identified as either foam cells or hemosidPDGF production. No message was detected over areas of
erin containing cells, did not appear to be a major site of
necrosis and only occasionally in cells in the underlying tunica
PDGF mRNA biosynthesis in the plaque. Few if any macro-

Willebrand's factor (vWf) mRNA (complementary to bases 3430-3481
[reference 39]) and to smooth muscle alpha-actin mRNA (60 bases
long complementary to the most 3' end of the coding region [40]); both
labeled by terminal transferase (41) using [35S]CTP (New England
Nuclear, Boston, MA; sp act 139 Ci/mmol). These probes specifically
hybridized to endothelial cells or medial smooth muscle cells, respectively. Only 1 of 8 carotid plaque samples failed to show hybridization
to these probes and was discarded from our analysis.
Identification of cell types. In an attempt to identify cell types
expressing PDGF in the plaque the in situ autoradiographed slides
were counterstained with hematoxylin and eosin and examined by
light microscopy at higher magnification. In some cases serial sections
were processed for immunocytochemistry using markers specific for
endothelial cells (anti-vWf; Vector Laboratories, Burlingame, CA;
Ulex Europaeus lectin binding [42, 43]), smooth muscle cells
(HHF-35; 44), T cells (anti-Leu4; Becton Dickinson Co., Oxnard, CA),
or macrophages (HAM56; 28). Immunocytochemistry was performed
according to the manufacturer's direction using the Vectastain ABC
alkaline phosphatase system (Vector Laboratories). The final reaction
product was stained with the alkaline phosphatase substrate kit I to
give a final stain that appeared red.
One technical problem encountered was that the HAM56 monoclonal antibody recognizes capillary endothelium as well as monocyte/macrophage appearing cells (28). However, on comparing serial
sections immunostained for HAM56 and either anti-vWf or Ulex
Europaeus lectin, it became apparent that endothelial cells were arranged either in a linear monolayer on the plaque surface, or as two to
five cells arranged as vascular profiles within the plaque. Individual
cells or cell clusters located elsewhere in the plaque, did not react with
either anti-vWf or Ulex Europaeus, but did react with the HAM56
antibody, and were therefore interpreted as monocyte/macrophages.
In agreement with previous studies (45) almost all cells with foamy
cytoplasm at the light microscope level (foam cells), reacted with the
HAM56 antibody but not with markers for endothelial cells or smooth
muscle cells.
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Figure 2. Localization of PDGF B chain mRNA in endothelial cells
of capillaries within the human atherosclerotic plaque (A and C) or
the normal internal mammary artery (E). Serial sections hybridized
with PDGF A chain specific probes showed little labeling of endothelial cells with much more intense hybridization to cells adjacent to
the endothelial layer (B and D arrows) or to mesenchymal-appearing

intimal cells (D). Serial sections from the internal mammary artery
specimen hybridized with PDGF A (F), PDGF receptor, or TGF-a
probes were negative. Specimens were photographed using a combination of polarized light epiluminescence and bright field illumination. (A and B) X125; (C-F) X310.

phages were considered positive for either A- or B-chain expression (Table I; Fig. 3 A). Serial sections stained for macrophage antigens by the Ham56 antibody suggested a very poor
correlation of PDGF expression with the localization of macrophages, in contrast to the correlation seen with the endothelial cell markers (Fig. 1). Preliminary studies combining in situ
hybridization for PDGF A-chain mRNA localization and
Ham56 immunocytochemistry on the same tissue section
confirm our impression that the macrophage contributes little

(if any) to local PDGF production in the atherosclerotic
plaque (Fig. 4). Similarly, no positive hybridizations to either
PDGF chain were seen among lymphocyte-appearing cells
(Fig. 3 A, Table I).
Although by autoradiographic grain intensity, B-chain hybridization was most intense among the endothelial-appearing
cells of plaque capillaries, the largest number cells positively
hybridized for B- and A-chain were noncapillary, mesenchymal-appearing intimal cells (Table I). Some of these cells had
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Table L Percentage ofAll Positive Hybridizations for PDGF
A-chain, B-chain, and PDGF Receptor mRNA Broken Down
by Cell Type

Hemosiderin/Foam
Capillary associated*
Lymphocytes
MICst
Medial cells

A-chain

B-chain

Receptor

6.3%
4.3%
0.1%
85.1%
3.9%

6.2%
15.9%
0.3%
75.0%
0.9%

4.4%
0.0%
0.4%
83.7%
11.2%

Cell counts were performed on four carotid endarterectomy specimens screened for PDGF A and B chain, and PDGF receptor gene
expression by in situ cRNA:mRNA hybridization. Random fields
were examined by light microscopy (at 400 magnification) to identify
cell type. Hybridization results and cell counts were pooled for all
four specimens for each probe. Results are expressed as the percentage of all positively hybridizing cells that fell into a particular cell
type category based on hematoxylin and eosin stain appearance. One
slide per probe for each specimen was used for counting, all with 6-7
wk autoradiography exposures. Cells with five or greater associated
autoradiographic grains were considered positive. Similar qualitative
results were evident on the remaining three carotid specimens studied.
* Capillary-associated cells include both endothelial cells and smooth
muscle cells.
t MICs, mesenchymal-appearing intimal cells.

the light microscopic appearance of smooth muscle cells, i.e.,
spindle-shaped cells with long, slender nuclei (Fig. 3 B) (47).
Many more cells had a stellate shape and displayed variable

amounts of cytoplasm (Fig. 3 A). However, most of the stellate
cells did not stain well with any of the cell type-specific antibodies used. Thus the identity ofthese cells remains somewhat
unclear.
Localization ofPDGF receptor to the arterial intima. All of
the samples so far discussed were hybridized in parallel with
PDGF receptor probe as well. Many cells in the intima of the
plaque make mRNA for PDGF receptor (Fig. 5 B). Again,
almost all such cells had the same mesenchymal morphology
as described above for the majority of A- and B-chain positive
cells. No lymphocyte-appearing cells, no endothelial-appearing cells, and almost no foam cells or hemosiderin-containing
cells were positive for PDGF receptor. Similarly, by serial section immunocytochemistry analysis, PDGF receptor positive
cells did not appear to react with monocyte/macrophage or
lymphocyte antibodies, nor did they show Ulex Europaeus
binding. PDGF receptor positive cells were distributed in regions previously seen to be A- or B-chain positive. In one
sample of coronary artery taken from a diseased heart removed during transplant surgery we found a diffuse intimal
thickening without atherosclerotic change, and with no evidence of macrophages or T cells. This sample was hybridized
with the PDGF receptor probe and displayed prominent labeling of the intimal cells (Fig. 5 A). Few PDGF receptor positive
cells were identified in the media of both this coronary artery
specimen and carotid plaques.

Discussion
Our data using in situ hybridization corroborate existing data
in demonstrating that PDGF mRNA is expressed in athero-

17

.%

V.V

A*

Figure 4. Demonstration that macrophages do not make PDGF A
chain mRNA in the human atherosclerotic plaque by simultaneous
in situ hybridization and immunocytochemistry. Frozen sections
were hybridized as described using the 35S-labeled PDGF A specific
riboprobe. After the posthybridization washes the tissue was stained

by immunocytochemistry using the HAM56 antibody as described
followed by dehydration and coating with emulsion. In preliminary
studies it was found that the prior processing of the tissue by the in
situ procedure intensified subsequent immunostaining. X3 1 0.
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sclerotic plaques. Expression of PDGF receptor, and its selective expression by the intimal mesenchymal cell, and not medial smooth muscle cells, establishes the presence of a target for
this agonist in the part ofthe vessel known to undergo selective
proliferation in atherosclerosis. The absence of medial cells
hybridizing with PDGF A- or B-chain or receptor probes suggests that either a fundamental change occurs in the smooth
muscle cells hypothesized to arrive in the intima from the
media (30), that some intimal mesenchymal cells may be in a
different stage of differentiation than the cells of the media
(48), or that intimal cells have in some way become transformed (49, 50). These are consistent with the finding that the
vessel wall contains different types of nonendothelial mesenchymal cells distinguished by their content of desmin and
smooth muscle-specific actin (51-54).
The idea that plaque growth is controlled by the production of growth factors by vessel wall cells themselves is intriguing for several reasons. Several forms of smooth muscle replication occur without platelet or leukocyte involvement, which
could act as a source of growth factors exogenous to the vessel
wall. This includes the response to hypertension (1 1-14) and
normal development. Endothelial cells are capable of producing PDGF in vitro but this ability depends on whether the cells
are proliferating as monolayer sheets or are stimulated to form
tubes (22); only the former form expresses significant levels of
PDGF. Perhaps controls exist in vivo, allowing the endothelium to respond to injury by producing PDGF, which then
initiates smooth muscle replication. Smooth muscle cells
taken from adult rat aorta do not produce PDGF except to a
small extent in primary culture (27). Cells taken from the same
vessel of newborn rats constitutively produce PDGF in culture
(25), a phenomenon also reported by Walker et al. (26) for cells
taken from the balloon injured carotid artery of adult rats.
These data imply that the ability to produce PDGF may be
under developmental control and may become remanifest
when smooth muscle cells are stimulated to respond to injury.
Alternatively, the local environment could regulate the production of PDGF by endothelial cells. Such factors as thrombin or transforming growth factor beta, or cAMP have been
shown to affect PDGF synthesis in capillary endothelial cells
(55) and may be produced at focal sites in the lesion.
Several caveats should be expressed. First, measurement of
mRNA contents by in situ hybridization is relative. Thus the
lack of hybridization seen among macrophage-appearing cells
does not exclude the possibility of low level expression of
PDGF by this cell type, but does suggest a higher level of
expression among nonmacrophage cells in the plaque. The
lack of PDGF production by macrophages was surprising since
these cells do make PDGF under appropriate in vitro conditions ( 18, 21). It is possible that macrophages produce PDGF
in atherosclerosis only when they first enter the lesion or with
some appropriate activation signal. It is important to realize
that the carotid atherosclerotic plaques we studied were advanced, complicated, and clinically significant lesions in individuals over 50 years old. Recent observations by Barrett and
Benditt (56) suggested that PDGF B chain is synthesized by
macrophages in human atherosclerotic plaques. This conclusion was based on their finding of a correlation between expression of PDGF B chain and fms by Northern blot analysis
of portions of carotid endarterectomy specimens. These data
are not necessarily in conflict with our results but may only
reflect strong PDGF expression in endothelial and intimal cells

Williams, S. M. Schwartz, and D. Gordon

in regions of the plaque rich in macrophages. The coronary
specimen with diffuse intimal thickening was interesting because it suggested that PDGF receptor expression may be a
feature of early intimal thickening or early atherosclerosis.
This finding must, however, be verified by studying earlier
lesions in younger individuals more extensively.
We have no direct evidence that the PDGF produced in the
plaque is stimulating replication. There are almost no data on
proliferation occurring in human arterial tissue. The studies
that have been performed using either in vitro thymidine labeling or flow cytometry have revealed labeling indices of < 0.1%
(57-59). Aside from being a mitogen, PDGF has other properties, including inducing chemotaxis and contraction of smooth
muscle cells (60-61). Therefore, if PDGF protein translation
and secretion are occurring in the atherosclerotic plaque, proliferation need not be the result. The detection of PDGF
mRNA and the identification of cells synthesizing it is a first
step in elucidating the possible sequence of events leading to
the development of the atherosclerotic plaque.
The nature of the mesenchymal-appearing intimal cell type
is not clear. By light microscopy (Fig. 3) these cells were of the
type sometimes called intimal smooth muscle cell (62), stellate
cells (63), or synthetic state smooth muscle cells (64). Our
failure to find a positive immunocytochemical marker for
these cells is not surprising. In previous immunocytochemical
and ultrastructural studies of the human atherosclerotic
plaque a significant number of intimal cells have remained
unidentified (28, 29, 62). The usual conclusion has been that
these cells are altered smooth muscle cells, since this cell type is
believed to be the sole connective tissue cell comprising the
inner tunica media from which the intimal cells are hypothesized to arise (30). Whatever its cell lineage, this cell comprises
a large portion of the human atherosclerotic intima and appears to be responsible for most of the local PDGF A chain
production.
One of the most striking features of atherosclerosis has
been the localization of proliferating smooth muscle cells to
the intima. Martin (65) proposed that this depends on loss of
contact dependent control of growth by sparsely scattered
smooth muscle cells in the intima. Benditt proposed that atherosclerosis represents a monoclonal, neoplastic growth at sites
of high mutagen accumulation due to lipid deposition (49, 50).
Ross and others have proposed that localization of proliferating smooth muscle cells depends on accumulation of toxic or
stimulatory products along a permeability gradient (30). None
of these ideas suggest the special properties that make intimal
smooth muscle cells proliferate. The focal nature of expression
of A chain mRNA by the scattered mesenchymal-appearing
intimal cells and the localization of receptor expression to the
intima may be important clues to identifying the special properties of intimal smooth muscle cells that may contribute to
the development of the atherosclerotic plaque.
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